Regional and International Students
In addition to working with undergraduate and graduate students from Albany College of Pharmacy and Health Sciences, PRI hosts students from other colleges and universities throughout the world.
Below is a representative list of institutions that have students to PRI to pursue their studies and embark on a research project:
- Ain Shams University (Egypt)
- Albany Medical Center (Albany, NY, USA)
- Alexandria University (Egypt)
- Cairo University (Egypt)
- King Saud University (Saudi Arabia)
- King Abdul-Aziz University (Saudi Arabia)
- Kuwait University
- Mansoura University (Egypt)
- Uludag University (Turkey)
- Umea University (Sweden)
- University at Albany (Albany, NY, USA)
- University of Indonesia (Jakarta, Indonesia)
- Zewail City of Science and Technology (Egypt)
The day included these awards:
Best PowerPoint Presentation: Kyleigh Chriss, Columbia High School, Decatur, GA
Best Poster Presentation: Ayush Karnik, Johns Creek High School, Johns Creek, GA
Plaques were presented to both Dr. Atul Laddu (GTF) and Ms. Ruth Russell (Questar) for: “Certificate of Achievement in recognition of your outstanding commitment and inspiration to the development of our future young scientists”.
Dr. Atul Laddu (far left), students, Dr. Mousa, and Ruth Russell (far right).
Photo of our Summer 2017 ACPHS PharmD rotation students and other student summer visitors. Left to right: Yahya Rasoully (ACPHS), Ali Nasser (ACPHS), Shiraz Umar (ACPHS), Dhruba Bharali (PRI), Shaker Mousa (PRI), Tyler Stone (ACPHS), Gulsen Coban (Uludag University, Bursa, Turkey), and Berfin Atli (Uludag University, Bursa, Turkey).
Our 2017 summer students are pictured here with their mentors. Left-to-right: Dr. Kavitha Godugu (mentor, PRI), Alina Mufti (Shaker High School, Latham, NY), Nancy Efstathiadis (Albany High School, Albany, NY), Harry Zay (Albany High School, Albany, NY), Dr. Shaker Mousa (mentor, PRI), Gulsen Coban (Uludag University, Bursa, Turkey), Jaehan Kim, (mentor, PRI/ACPHS, PharmD Candidate, Class of 2019).
Dr. Shimaa Motawei (pictured, center) from Mansoura University, Faculty of Medicine, in Mansoura, Egypt was a Fullbright Scholar at PRI for 6 months, through May, 2017. Her PRI research project was to study harmful effects of lead during pregnancy using a mouse model. Lead toxicity still constitutes a public health problem in many countries. It adversely affects angiogenesis, a pivotal process in growth, development, and repair. Disturbance of angiogenesis during pregnancy contributes to incidence of pre-eclampsia and small size for gestational age fetuses. Dr. Motawei studied lead effects on angiogenesis and any possible protective effect of a sulfated non-anticoagulant low molecular weight heparin, S-NACH. Her goal was to determine if S-NACH could reverse any harmful effects during pregnancy, in particular because S-NACH does not cross the placenta.
Mary Adeyeye has been accepted to the University of Texas Health Science Center, Houston, for an MD/PhD degree beginning August 2017. Mary, an undergraduate student at SUNY Albany, worked with PRI staff member Mehdi Rajabi as part of the UAlbany Summer Research Program and Collegiate Science & Technology Entry Program (CSTEP). Mary is a coauthor with Mehdi Rajabi, Schuyler Pruyn, and Dr. Mousa on a book chapter that has been submitted for peer review, titled, “Pharmaceutical Applications of Water-Soluble Polymers in Nanomedicine and Drug Delivery”.
Summer Students 2015
From left to right: Taha Ahmed, Abrahim Rehman, Vandhana M-Chari (mentor), Donniecia Corke, Kimberly Guzman Reyes, Emanuel Gomez, Benjamin Braun, Juan Perez.
Donniecia Corke is an undergraduate from U Albany and did research at PRI for 8 weeks as part of UASRP (U Albany Summer Research Program). The others are high school students and did research at PRI for 6 weeks: Kim and Emanuel came as part of the ACPHS High School Summer Research Program, and Kim was sponsored by Albany’s Light Summer Youth Employment Program. They tested and compared the anti-coagulatory (high schoolers and Donniecia) and anti-inflammatory (Donniecia) efficiency of various test compounds to USP heparin.